The Role of a Clinical Pharmacist in Melanoma Care and Education

Source: Pharmacy Times, April 2022

Because of the likelihood that patients with melanoma will develop adverse effects on therapy, it is crucial for pharmacists to proactively educate patients and provide them with tools to help mitigate and manage these issues.

It is estimated that 99,780 people in the United States will be diagnosed with melanoma in 2022.1 Although the average age at diagnosis is 63, melanoma is the most frequently diagnosed cancer in those ages 25-29.

Providers have estimated that more than 80% of patients experience adverse effects (AEs) while receiving combination immunotherapy for melanoma. Having close contact with the medical team is vital to not only preventing these AEs, but managing them as they arise.